Dr. R. Andre Raposo leads the Analytical Automation Group within Platform Research at Oxford Biomedica. Dr. Raposo’s team has conceptualised and implemented automated solutions to increase throughput, maximise precision and reduce operator error to successfully meet the challenges for process development and commercial supply of lentiviral vector. Dr. Raposo acquired his PhD in HIV Immunology at the University of Oxford and worked as postdoc at the University of California San Francisco and The George Washington University in the USA. Dr. Raposo has an interest in understanding the molecular pathways by which viruses evade the immune system and during his academic career he has helped to characterise host intrinsic factors used by cells to counteract HIV-1.
November 14, 2019
The Connected Lab
- 1:50 pmComputer-Aided Biology: How Automation and Digital Tools are Transforming R&D Labs